Patents by Inventor Maryka Quik

Maryka Quik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180110768
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: June 1, 2017
    Publication date: April 26, 2018
    Inventors: Maryka QUIK, Donato DI MONTE, J. William LANGSTON
  • Publication number: 20160235732
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: September 10, 2015
    Publication date: August 18, 2016
    Inventors: Maryka QUIK, Donato DI MONTE, J. William LANGSTON
  • Publication number: 20110077276
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: October 8, 2010
    Publication date: March 31, 2011
    Inventors: Maryka QUIK, Donato Di Monte, J. William Langston
  • Publication number: 20100196463
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: August 4, 2009
    Publication date: August 5, 2010
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston
  • Publication number: 20100166735
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: August 4, 2009
    Publication date: July 1, 2010
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston
  • Publication number: 20100159004
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: August 4, 2009
    Publication date: June 24, 2010
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston
  • Publication number: 20100158895
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: August 4, 2009
    Publication date: June 24, 2010
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston
  • Patent number: 7718677
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Grant
    Filed: April 2, 2008
    Date of Patent: May 18, 2010
    Assignee: Parkinson's Institute
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston
  • Publication number: 20100029723
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: July 14, 2009
    Publication date: February 4, 2010
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston
  • Publication number: 20080260825
    Abstract: The invention provides compositions and methods utilizing a nicotinic receptor modulator, e.g., to reduce or eliminate a side effect associated with dopaminergic agent treatment. In some embodiments, the invention provides compositions and methods utilizing a combination of a dopaminergic agent and a nicotinic receptor modulator that reduces or eliminates a side effect associated with dopaminergic agent treatment.
    Type: Application
    Filed: April 2, 2008
    Publication date: October 23, 2008
    Inventors: Maryka Quik, Donato Di Monte, J. William Langston